Mironova M I, Lyskovtsev V V, Kaverina N V
Farmakol Toksikol. 1990 May-Jun;53(3):65-7.
The brief data on the results of the clinical trials of a new antiarrhythmic drug bonnecor at intravenous administration performed in six clinical institutions of the country are presented. A high effectiveness and a good tolerance of the drug in VT, VE, ST, SE and WPW syndrome were revealed.
本文介绍了在该国六个临床机构进行的新型抗心律失常药物bonnecor静脉给药临床试验结果的简要数据。结果显示该药物对室性心动过速、室性早搏、房性心动过速、房性早搏和预激综合征具有高效性和良好耐受性。
